Acute bronchial asthma.
Advances in the understanding of the pathophysiology of acute asthma have been reflected in the changing patterns of present treatment and future research. Monitoring objectively the severity of the airway obstruction and its response to treatment will further make the care of the asthmatic patient a more rational event.
D000208:Acute Disease; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000336:Aerosols; D000402:Airway Obstruction / Q000503:physiopathology; D001249:Asthma / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology*; D001986:Bronchial Spasm / Q000188:drug therapy; D006801:Humans; D009093:Mucus / Q000378:metabolism; D009130:Muscle, Smooth / Q000503:physiopathology; D005996:Nitroglycerin / Q000627:therapeutic use; D010276:Parasympatholytics / Q000627:therapeutic use; D011453:Prostaglandins / Q000627:therapeutic use; D012137:Respiratory System / Q000503:physiopathology; D013806:Theophylline / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000317:Adrenergic alpha-Antagonists; D000318:Adrenergic beta-Agonists; D000336:Aerosols; D010276:Parasympatholytics; D011453:Prostaglandins; D013806:Theophylline; D005996:Nitroglycerin